Asenapine once daily versus twice daily: Impact on patient acceptance in a randomized, open-label, 14-day clinical trial

Xiaowei Sun, Robert Hamer, Joseph McEvoy

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Asenapine once daily versus twice daily: Impact on patient acceptance in a randomized, open-label, 14-day clinical trial'. Together they form a unique fingerprint.